https://www.cnbc.com/2023/11/27/mounjaro-superior-to-ozempic-for-weight-loss-study-says.html
0
0
11/27/23 at 2:00pm
Organization
CNBC
Author
Annika Kim Constantino
46 words
0
Comments
Patients on Eli Lilly's Mounjaro were more likely to lose weight and experienced larger reductions in body weight compared to those on Novo Nordisk's Ozempic.
You are the first to view
Create an account
or login to join the discussion